title: The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
authors.forename: T
authors.initials: T
authors.lastname: Nagatani
authors.forename: S
authors.initials: S
authors.lastname: Ichiyama
authors.forename: R
authors.initials: R
authors.lastname: Onuma
authors.forename: M
authors.initials: M
authors.lastname: Miyazawa
authors.forename: T
authors.initials: T
authors.lastname: Matsuzaki
authors.forename: K
authors.initials: K
authors.lastname: Miyagawa
authors.forename: N
authors.initials: N
authors.lastname: Baba
authors.forename: M
authors.initials: M
authors.lastname: Uchiyama
authors.forename: H
authors.initials: H
authors.lastname: Nakajima
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003606:Dacarbazine / Q000008:administration & dosage; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy; D016899:Interferon-beta / Q000008:administration & dosage*; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality; D015376:Nimustine / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015376:Nimustine; D014750:Vincristine; D016899:Interferon-beta; D003606:Dacarbazine